Covidien warns customers in the U.S. and Bermuda that some of its Monoject syringes were mislabeled and not properly sterilized, prompting the company to recall 6 lots of the device.
Covidien (NYSE:COV) recalled some lots of its Monoject syringes after discovering a sterilization mishap and labeling problem.
The issues affected 6 lots in shipments that went out to customers in the U.S. and Bermuda, the Mansfield, Mass.-based medical products giant said.
A Delaware state jury finds that Covidien's ev3 subsidiary broke its deal for a $175 million milestone payment to Appriva Medical, awarding the milestone nut plus interest.
Covidien (NYSE:COV) is on the hook for a $175 million milestone owed by subsidiary ev3 Inc. to a company it acquired 11 years ago, plus another possible $100 million in interest, after a Delaware jury's decision last May.
A federal judge tosses 1 count of a patent infringement lawsuit filed by Covidien's Nellcor subsidiary against CAS Medical over patient monitoring technology.
SetPoint Medical raises $27 million, including contributions from Boston Scientific, Covidien and GlaxoSmithKline's new venture investing arm.
SetPoint Medical said Boston Scientific (NYSE:BSX) and Covidien (NYSE:COV) were among the participants in a $27 million funding round.
Covidien shares are up this morning after the medical device company beat earnings expectations with its fiscal 3rd-quarter results.
Covidien (NYSE:COV) shares gained on Wall Street today after the medical device company said its fiscal 3rd-quarter earnings beat analysts' predictions.
Mansfield, Mass.-based Covidien posted profits of $396.0 million, or 84¢ per share, on sales of $2.58 billion during the 3 months ended June 28.
Group purchasing organization Premier inked a deal with Olympus America for the company's Thunderbeat surgical tool, signing it up under the GPO’s program for innovative new technologies.
Olympus America, a Center Valley, Pa.-based commercial camera and medical supply maker, landed a contract to supply surgical tools to members of group purchasing organization Premier healthcare alliance.
ArjoHuntleigh lured a former Covidien executive as its new president of North American operations.
Illinois healthcare products maker ArjoHuntleigh hired Rick Lytle, a former Covidien (NYSE:COV) executive, as the new president of company operations in the U.S. and Canada.